
The authors summarize the results of the September 2000 PhRMA workshop discussions about conducting out-of-specification investigations.
Sol Motola, PhD, is the assistant vice-president of technical and regulatory affairs for Wyeth Ayerst Global Pharmaceuticals, St. Davids, PA.

The authors summarize the results of the September 2000 PhRMA workshop discussions about conducting out-of-specification investigations.

Published: January 1st 2002 | Updated: